Comorbidity of irritable bowel syndrome in psychiatric patients: a review.
Comorbidity of irritable bowel syndrome in psychiatric patients: a review.
复制标题
DOI：
10.1097/00045391-200301000-00014
复制
发表时间：
2003-01-01
影响因子：
4.2
通讯作者：
Masand, Prakash S
中科院分区：
文献类型：
--
作者：
Garakani, Amir;Win, Terrance;Masand, Prakash S
肠易激综合征（IBS）是一种功能性胃肠道疾病，在美国成年人中有10%到20%的人患有此病。该综合征最好的定义是慢性腹部不适，伴有大便频率、稠度和通过的改变，并伴有腹部腹胀或粪便中存在粘液等相关症状。几项研究表明，在寻求治疗的肠易激综合征患者中，高达70%至90%的人患有精神疾病，最明显的是情绪和焦虑障碍。最近的研究表明，在寻求治疗的精神病人中，肠易激综合症的患病率很高，其中精神分裂症的患病率为19%，重度抑郁症的患病率为29%，其他疾病中的恐慌症的患病率为46%。我们的文章回顾了IBS在精神病患者中的合并症，并讨论了治疗的意义。
Irritable bowel syndrome (IBS), a functional gastrointestinal disorder, is present in 10% to 20% of the U.S. adult population. The syndrome is best defined as chronic abdominal discomfort with changes in stool frequency, consistency, and passage, with associated symptoms such as abdominal bloating or presence of mucus in stools. Several studies have shown that up to 70% to 90% of patients with IBS who seek treatment have psychiatric comorbidity, most notably mood and anxiety disorders. Recent studies have shown a high prevalence of IBS in psychiatric patients who seek treatment, with a prevalence of 19% in schizophrenia, 29% in major depression, and 46% in panic disorder among other disorders. Our article reviews the comorbidity of IBS in psychiatric patients and discusses implications for treatment.